Yuen Maggie sold $134K of ATRC
Yuen Maggie sold 3,500 shares of AtriCure, Inc. (ATRC) at $38.42 ($0.13M total) on 2026-08-05.
How this was made
The 30-second read
Why it matters
The only new information is the director’s sale size, price, and post-transaction holdings; it does not include guidance, clinical, regulatory, or deal updates.
Market read
Traders may note insider selling as a sentiment datapoint, but there is no fundamental catalyst in the filing.
What to watch
No 10b5-1 plan is disclosed, but insider sales can still be scheduled or driven by personal tax/financial planning; without additional context, signal quality is low.
Background
The article is a SEC Form 4 insider transaction disclosure for AtriCure, Inc.
Ticker impact
AtriCure director Yuen Maggie sold 3,500 shares on 2026-08-05 at $38.42, totaling $134,470, per Form 4.
Likely limited near-term impact; any effect would be sentiment-driven rather than earnings or guidance-related.
Form 4 insider sales are common and often non-informational; the filing provides transaction details but no new company-specific operating or financial information.
Market effects
No clear sector read-through from a single director sale.
None indicated.
None indicated.
Counterpoint
The sale may be routine liquidity or diversification, especially since the filing does not state any adverse company development.
Key entities
- issuerAtriCure, Inc.
US-listed company whose director insider sale is disclosed via Form 4.
- insiderYuen Maggie
Director who sold 3,500 shares at $38.42 on 2026-08-05.
